Paul Wang to Nanotechnology
This is a "connection" page, showing publications Paul Wang has written about Nanotechnology.
Connection Strength
1.350
-
Korotcov A, Shan L, Meng H, Wang T, Sridhar R, Zhao Y, Liang XJ, Wang PC. A nanocomplex system as targeted contrast agent delivery vehicle for magnetic resonance imaging dynamic contrast enhancement study. J Nanosci Nanotechnol. 2010 Nov; 10(11):7545-9.
Score: 0.349
-
Liang XJ, Chen C, Zhao Y, Wang PC. Circumventing tumor resistance to chemotherapy by nanotechnology. Methods Mol Biol. 2010; 596:467-88.
Score: 0.329
-
Wang PC, Blumenthal RP, Zhao Y, Schneider JA, Miller N, Grodzinski P, Gottesman MM, Tinkle S, Wang K, Wang C, Liang XJ. Building scientific progress without borders: nanobiology and nanomedicine in China and the U.S. Cancer Res. 2009 Jul 01; 69(13):5294-5.
Score: 0.317
-
Huo S, Jin S, Ma X, Xue X, Yang K, Kumar A, Wang PC, Zhang J, Hu Z, Liang XJ. Ultrasmall gold nanoparticles as carriers for nucleus-based gene therapy due to size-dependent nuclear entry. ACS Nano. 2014 Jun 24; 8(6):5852-62.
Score: 0.112
-
Lin PC, Lin S, Wang PC, Sridhar R. Techniques for physicochemical characterization of nanomaterials. Biotechnol Adv. 2014 Jul-Aug; 32(4):711-26.
Score: 0.108
-
Chen S, Yang K, Tuguntaev RG, Mozhi A, Zhang J, Wang PC, Liang XJ. Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance. Nanomedicine. 2016 Feb; 12(2):269-86.
Score: 0.031
-
Xue X, Hall MD, Zhang Q, Wang PC, Gottesman MM, Liang XJ. Nanoscale drug delivery platforms overcome platinum-based resistance in cancer cells due to abnormal membrane protein trafficking. ACS Nano. 2013 Dec 23; 7(12):10452-64.
Score: 0.027
-
Meng J, Wang DL, Wang PC, Jia L, Chen C, Liang XJ. Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics. J Nanosci Nanotechnol. 2010 Dec; 10(12):8610-6.
Score: 0.022
-
Liang XJ, Meng H, Wang Y, He H, Meng J, Lu J, Wang PC, Zhao Y, Gao X, Sun B, Chen C, Xing G, Shen D, Gottesman MM, Wu Y, Yin JJ, Jia L. Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis. Proc Natl Acad Sci U S A. 2010 Apr 20; 107(16):7449-54.
Score: 0.021
-
Yin JJ, Lao F, Meng J, Fu PP, Zhao Y, Xing G, Gao X, Sun B, Wang PC, Chen C, Liang XJ. Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger. Mol Pharmacol. 2008 Oct; 74(4):1132-40.
Score: 0.019
-
Pirollo KF, Dagata J, Wang P, Freedman M, Vladar A, Fricke S, Ileva L, Zhou Q, Chang EH. A tumor-targeted nanodelivery system to improve early MRI detection of cancer. Mol Imaging. 2006 Jan-Mar; 5(1):41-52.
Score: 0.016